Literature DB >> 25840793

Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity?

G Bedogni1, G Grugni, G Tringali, N Marazzi, A Sartorio.   

Abstract

BACKGROUND: Subjects with Prader-Willi syndrome (PWS) have a higher fat mass and a lower fat-free mass compared to subjects with essential obesity. However, few data are presently available on the segmental body composition (BC) of PWS subjects. AIM: To evaluate whether women with PWS and women with essential obesity, matched for age and percent body fat, differ in segmental fat distribution and surrogate markers of cardiometabolic disease (CMD). SUBJECTS AND METHODS: 35 women with PWS and 50 women with essential obesity were matched for age and percent body fat using coarsened exact matching. BC was measured by dual-energy X-ray absorptiometry. Oral glucose tolerance testing and measurements of cholesterol, triglycerides, C-reactive protein, and blood pressure were performed. Comparisons between PWS and obese women were performed using generalized linear models.
RESULTS: Trunk fat was lower in PWS than in obese women on both absolute [-7.3 (95% confidence interval -9.4 to -5.2) kg] and relative [-4.1 (-6.9 to -1.4)% of body fat] grounds. PWS and obese women had similar surrogate markers of CMD, with the exception of HDL-cholesterol, which was higher in PWS women.
CONCLUSION: Trunk fat is lower in obese women with PWS than in those with essential obesity. Surrogate markers of CMD are, however, mostly similar in the two groups.

Entities:  

Mesh:

Year:  2015        PMID: 25840793     DOI: 10.1007/s40618-015-0266-y

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  A distinctive obesity: body composition provides the clue.

Authors:  G B Forbes
Journal:  Am J Clin Nutr       Date:  1997-05       Impact factor: 7.045

3.  Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance.

Authors:  Alexander Viardot; Lisa Sze; Louise Purtell; Amanda Sainsbury; Georgina Loughnan; Ellie Smith; Herbert Herzog; Katharine Steinbeck; Lesley V Campbell
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

4.  Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment.

Authors:  Yuriko Tanaka; Yoshiko Abe; Yuji Oto; Hisashi Itabashi; Masahisa Shiraishi; Atsunori Yoshino; Kazuo Obata; Nobuyuki Murakami; Toshiro Nagai
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

5.  Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.

Authors:  Rasmus Sode-Carlsen; Stense Farholt; Kai Fr Rabben; Jens Bollerslev; Thomas Schreiner; Anne Grethe Jurik; Jens Sandahl Christiansen; Charlotte Höybye
Journal:  Growth Horm IGF Res       Date:  2010-03-03       Impact factor: 2.372

6.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

7.  Assessment of fat-free mass from bioelectrical impedance analysis in obese women with Prader-Willi syndrome.

Authors:  Giorgio Bedogni; Graziano Grugni; Gabriella Tringali; Fiorenza Agosti; Alessandro Sartorio
Journal:  Ann Hum Biol       Date:  2014-12-26       Impact factor: 1.533

8.  Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity.

Authors:  P Brambilla; A Crinò; G Bedogni; L Bosio; M Cappa; A Corrias; M Delvecchio; S Di Candia; L Gargantini; E Grechi; L Iughetti; A Mussa; L Ragusa; M Sacco; A Salvatoni; G Chiumello; G Grugni
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-01-20       Impact factor: 4.222

9.  In-vivo precision of the GE Lunar iDXA densitometer for the measurement of appendicular and trunk lean and fat mass.

Authors:  K Hind; B Oldroyd
Journal:  Eur J Clin Nutr       Date:  2013-10-30       Impact factor: 4.016

10.  Magnetic resonance imaging of total body fat.

Authors:  E L Thomas; N Saeed; J V Hajnal; A Brynes; A P Goldstone; G Frost; J D Bell
Journal:  J Appl Physiol (1985)       Date:  1998-11
View more
  7 in total

Review 1.  Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.

Authors:  Antonino Crinò; Graziano Grugni
Journal:  Curr Diab Rep       Date:  2020-02-06       Impact factor: 4.810

Review 2.  Obesity management in Prader-Willi syndrome: current perspectives.

Authors:  Antonino Crinò; Danilo Fintini; Sarah Bocchini; Graziano Grugni
Journal:  Diabetes Metab Syndr Obes       Date:  2018-10-04       Impact factor: 3.168

3.  The Sun's Vitamin in Adult Patients Affected by Prader-Willi Syndrome.

Authors:  Luigi Barrea; Giovanna Muscogiuri; Gabriella Pugliese; Sara Aprano; Giulia de Alteriis; Carolina Di Somma; Annamaria Colao; Silvia Savastano
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

Review 4.  Do patients with Prader-Willi syndrome have favorable glucose metabolism?

Authors:  Yanjie Qian; Fangling Xia; Yiming Zuo; Mianling Zhong; Lili Yang; Yonghui Jiang; Chaochun Zou
Journal:  Orphanet J Rare Dis       Date:  2022-05-07       Impact factor: 4.303

5.  Circulating microRNA Associated to Different Stages of Liver Steatosis in Prader-Willi Syndrome and Non-Syndromic Obesity.

Authors:  Muhammad Yogi Pratama; Devis Pascut; Sofia Tamini; Alessandro Minocci; Claudio Tiribelli; Graziano Grugni; Alessandro Sartorio
Journal:  J Clin Med       Date:  2020-04-14       Impact factor: 4.241

6.  Changes of Body Weight and Body Composition in Obese Patients with Prader-Willi Syndrome at 3 and 6 Years of Follow-Up: A Retrospective Cohort Study.

Authors:  Giorgio Bedogni; Graziano Grugni; Sabrina Cicolini; Diana Caroli; Sofia Tamini; Alessandro Sartorio
Journal:  J Clin Med       Date:  2020-11-08       Impact factor: 4.241

Review 7.  Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.

Authors:  G Muscogiuri; L Barrea; F Faggiano; M I Maiorino; M Parrillo; G Pugliese; R M Ruggeri; E Scarano; S Savastano; A Colao
Journal:  J Endocrinol Invest       Date:  2021-04-23       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.